How to decide between medicine to help you sleep and CBT-I

If you are choosing between CBT-I and medicine to help you sleep, the first question is not which one is “stronger.” It is what kind of sleep problem you are dealing with. Insomnia that has lasted more than three months is usually a different decision from a week of sleeplessness after a crisis, a new diagnosis, travel, pain, caregiving stress, or a frightening stretch at work.

For chronic insomnia, cognitive behavioral therapy for insomnia, or CBT-I, is the treatment to look at first when you can get it. Mayo Clinic describes CBT-I as “generally the best treatment for ongoing insomnia,” and that wording matters: it is not presented as a wellness preference or a last resort after pills fail, but as the main treatment for the condition itself.[1]

What sleep medicine can realistically do

Sleep medication is not fake help. For someone who has not slept for days and has to drive, work, parent, or make decisions, even one better night can matter. The problem is that the average benefit is smaller than many people expect. Cleveland Clinic summarizes sleep-aid effects this way: people taking them may fall asleep about 8 to 20 minutes faster and get roughly 35 minutes more sleep on average.[2]

That is a real effect, but it is not the same as restoring healthy sleep. It also does not answer the longer question: what happens when the pill stops? One of the most important differences between medication and CBT-I is that medication benefit often fades after discontinuation, while CBT-I is designed to leave the sleeper with skills that continue after treatment ends.[3]

This is where nightly use can become oddly quiet. The first prescription, or the first bottle from the drugstore, may have been reasonable. A bad divorce week. A death in the family. A flare of pain. A red-eye schedule. But six months later, the original emergency may be gone, the sleep may not be much better, and the risk is still arriving every night.

Why CBT-I is treated as first-line for chronic insomnia

CBT-I is not simply “sleep hygiene.” It usually works on the learned patterns that keep insomnia going: spending too much wakeful time in bed, trying harder and harder to sleep, irregular sleep timing, catastrophic thoughts about the next day, and habits that make the bed feel like a place for monitoring failure instead of sleeping.

That distinction matters because many adults have already tried the easy advice. They have bought the blackout curtains, stopped late coffee, downloaded the meditation app, and still spend the night calculating how badly tomorrow will go. CBT-I is more structured than general advice. It often includes sleep restriction, stimulus control, cognitive work, relaxation strategies, and relapse planning.

The main advantage is durability. A medication can push a night in the right direction while it is active in the body. CBT-I tries to change the conditions that make insomnia self-sustaining. That is why guidelines and major clinical resources tend to place CBT-I ahead of medication for ongoing insomnia, even though medication may feel more immediate on a bad night.[1]

When medication is a reasonable choice

The cleanest case for sleep medication is acute insomnia: a defined, short-term disruption where the goal is to get through a rough patch without turning a temporary problem into a chronic one. In that setting, a clinician may consider a short course, especially when the consequences of not sleeping are immediate and serious.

Medication can also function as a bridge. CBT-I does not always feel helpful on night one. Some parts, especially sleep restriction, can temporarily make a person feel more tired before sleep consolidates. For a patient who is terrified of another sleepless night, a brief medication plan may make it possible to begin behavioral treatment instead of abandoning it.

There are also practical cases where “try CBT-I” is correct medically but incomplete as advice. Some people cannot find a trained provider. Some have insurance that will not cover it. Some work shifts that make weekly appointments nearly impossible. Some are caring for a baby, a spouse, or a parent and cannot protect a consistent sleep window. Patient preference includes those facts, not just taste.

Prescription sleep medications also differ from one another, and the right choice depends on age, other medications, alcohol use, breathing problems, pregnancy status, mental health history, and next-day responsibilities. Mayo Clinic’s prescription sleeping pill guidance emphasizes that these medicines require individualized discussion rather than casual long-term use.[4]

The bridge should have an exit

A bridge plan is different from an indefinite plan. Before a sleep aid becomes nightly, it is worth asking three plain questions: what problem is this treating, how will we know it is still helping, and what replaces it when we stop?

• If the sleep aid was started for a short-term event, set a reassessment date rather than letting refills make the decision.
• If it is being used while starting CBT-I, define whether it is for every night, selected nights, or only severe nights.
• If the benefit is fading, do not keep escalating without revisiting the diagnosis, dose, interactions, and nonmedication plan.
• If stopping causes rebound insomnia, tapering and behavioral support may be safer than a sudden stop.

Combination treatment is useful, but it does not make pills the foundation

Medication and CBT-I are sometimes framed as opposites. In practice, they can overlap. A 2023 JAMA Network Open study compared digital CBT-I with medication therapy among patients with insomnia, and the broader evidence discussion around digital CBT-I suggests that behavioral treatment can be meaningfully effective even when delivered outside the traditional therapist office model.[3]

A SLEEP 2025 abstract, discussed in Nature, reported that digital CBT-I plus medication may produce significantly greater effectiveness than either approach alone.[5] That is useful, but it should not be stretched into a simple message that chronic nightly medication is now the preferred path. Abstracts and early reports are signals to watch, not the same thing as settled long-term guidance for every adult with insomnia.

The practical reading is narrower: for some people, especially those in severe distress or those who cannot tolerate the first phase of CBT-I without help, a combined plan may be reasonable. The medication should still have a job description. It is there to reduce acute suffering, support participation, or manage a defined period of risk. It is not there to quietly replace the work that makes sleep more stable after the prescription ends.

OTC sleep aids are not automatically safer because they are easy to buy

Drugstore sleep aids can feel less serious than prescriptions, partly because they sit next to cold medicine and vitamins. Many contain sedating antihistamines. Harvard Health cautions that drugstore sleep aids may bring more risks than benefits, particularly because next-day grogginess, confusion, urinary problems, constipation, and fall risk can matter more than people expect.[6]

They may also stop feeling effective quickly for some users. That does not mean every person who takes an OTC sleep aid is doing something dangerous, but it does mean “available without a prescription” is not the same as “good for nightly insomnia.” For a closer look at that pattern, see why Unisom SleepGels can stop working after a few nights.

Older adults need a stricter safety filter

The risk-benefit balance changes with age. A medicine that produces tolerable next-day grogginess at 35 can contribute to falls, confusion, memory problems, or dangerous interactions at 75. The concern is not theoretical caution; it is that many older adults who take sleep medicine may not be good candidates for it. Available evidence notes an older-adult mismatch: only about 1 in 3 older adults taking sleep medicine may be appropriate candidates, and nondrug approaches are strongly preferred for patients over 65.[7]

This is one reason chronic insomnia in older adults should not be reduced to “they need something stronger.” Sometimes the safer intervention is a medication review, pain assessment, alcohol review, sleep apnea evaluation, depression or anxiety care, or CBT-I adapted to the person’s actual schedule and health limits.

For readers making decisions for themselves or a parent, the Beers Criteria and sleep aids for older adults are worth reviewing before treating a nightly pill as harmless background noise.

Off-label prescriptions deserve the same scrutiny

Some medicines used for insomnia were not originally developed as sleeping pills. Trazodone is a common example: it is often prescribed off-label when clinicians want to avoid certain controlled substances or when depression, anxiety, or other factors complicate the picture. Off-label does not automatically mean inappropriate. It does mean the decision should be specific: why this drug, for this person, at this dose, for this length of time?

That question is especially important when a medication is used because it seems familiar or less risky than the alternatives. Familiarity can dull attention to side effects, interactions, and next-day impairment. For more detail on that particular medication choice, see trazodone for insomnia and adult risk considerations.

If CBT-I is hard to access

Access is the part of the recommendation that often gets flattened. It is easy to say CBT-I is first-line. It is harder to be the person calling providers, discovering a year-long wait list, finding out the program is not covered, or trying to do sleep restriction while working an unpredictable schedule. Nature reported in 2025 that CBT-I wait lists can be as long as a year in some settings, citing sleep specialist Andrew Krystal.[5]

Digital CBT-I can help narrow that gap, but it should be discussed carefully. Nature’s 2025 article described expanding digital CBT-I options and noted SleepioRx as FDA-cleared in 2024, with reported trial efficacy of 76%.[5] As of Q3 2026, product availability, prescription requirements, payer coverage, and regulatory status should be checked directly before assuming any specific app or program is usable for a particular patient.

For many adults, the realistic sequence is not pure CBT-I versus pure medication. It may be digital CBT-I now, a wait-list spot for a clinician later, and a short-term medication plan only if the sleep loss is becoming unsafe. If you have already decided that online CBT-I is the most realistic route, the narrower comparison in online CBT-I vs. sleep medication may be the more useful next read.

A practical access plan

• Ask your primary-care clinician whether your insomnia pattern fits chronic insomnia, acute insomnia, circadian disruption, sleep apnea, restless legs, pain-related waking, medication side effects, anxiety, depression, or substance-related sleep disruption.
• Search for CBT-I through sleep clinics, behavioral sleep medicine providers, psychologists, academic medical centers, and telehealth options.
• If in-person CBT-I is unavailable, consider a reputable digital CBT-I program while verifying current access and cost.
• If medication is used during the wait, agree in advance on duration, dose, reassessment, driving or work precautions, and what nonmedication treatment is being built underneath it.

How to decide this week

A person who has slept three hours a night all week may not need a lecture about long-term durability before tomorrow morning. But the decision still needs a time horizon. Medication can be appropriate when the immediate cost of not sleeping is high. CBT-I becomes more important as the pattern persists, especially once insomnia has crossed into months rather than days.

For chronic insomnia, start with CBT-I when possible. Use medicine selectively, briefly, and with a plan for what replaces it when the pill stops being the main tool.

References

1. Insomnia treatment: Cognitive behavioral therapy instead of sleeping pills, Mayo Clinic
2. Sleeping Pills: How They Work, Side Effects, Risks & Types, Cleveland Clinic
3. Comparative Effectiveness of Digital Cognitive Behavioral Therapy vs Medication Therapy Among Patients With Insomnia, JAMA Network Open, 2023
4. Prescription sleeping pills: What's right for you?, Mayo Clinic
5. New treatments to put insomnia to bed, Nature, 2025
6. Drugstore sleep aids may bring more risks than benefits, Harvard Health
7. A year of momentum for sleep medicine: 2025 recap, American Academy of Sleep Medicine